Anti-hyperlipidemia drug improves brain connectivity in mouse models of schizophrenia
New therapies that improve connectivity and circuitry in the brain of people with schizophrenia could result from the discovery by a RIKEN-led team of a potential new target for drugs to treat the psychiatric disorder.